SHIRE PHARMACEUTICALS GROUP PLC
S-3, EX-23.2, 2000-06-06
PHARMACEUTICAL PREPARATIONS
Previous: SHIRE PHARMACEUTICALS GROUP PLC, S-3, EX-23.1, 2000-06-06
Next: SHIRE PHARMACEUTICALS GROUP PLC, S-3, EX-23.3, 2000-06-06






                         Consent of Independent Auditors

     We consent to the reference to our firm under the caption "Experts" in the
Registration Statement on Form S-3 and related Prospectus of Shire
Pharmaceuticals Group plc for the registration of 533,279 of its ordinary shares
and to the incorporation by reference therein of our report dated February 16,
1999, with respect to the consolidated financial statements of Roberts
Pharmaceutical Corporation for the year ended December 31, 1998, included in the
Shire Pharmaceuticals Group plc Annual Report on Form 10-K for the year ended
December 31, 1999, filed with the Securities and Exchange Commission.


                                                       /s/ Ernst & Young LLP

MetroPark, New Jersey
June 6, 2000





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission